What are the main drawbacks of St. John’s wort?

    Last Updated: October 25, 2023

    Studies have shown that HP can interfere with the expression of enzymes of the cytochrome-P (CYP) family[1] and of P-glycoprotein, both of which play a role in the metabolism of various medications. This can result in altered effects of certain drugs, potentially leading to reduced effectiveness or unexpected outcomes. Common medications whose effect may be decreased by HP include some oral contraceptive pills, warfarin (an anticoagulant drug), cyclosporin (often used as an immunosuppressant in organ transplants),[2] digoxin (mostly used for atrial fibrillation), proton pump inhibitors (used to reduce stomach acid production), and some statins (cholesterol-lowering drugs).[3][4]

    Furthermore, combining HP with other antidepressants that increase serotonin levels (e.g., SSRIs, MAOIs) may raise the risk of serotonin syndrome (or serotonin toxicity), a potentially life-threatening condition characterized by an excessive accumulation of serotonin in the system. Symptoms of serotonin syndrome include tachycardia, increased blood pressure, dilated pupils, sweating, and elevated body temperatures.[5] More data is required to verify the level of interaction with such medications.

    Although St. John’s wort has been associated with fewer side effects compared to some antidepressant medications, the most common side effects reported with its use include gastrointestinal issues (e.g., abdominal pain or discomfort, nausea, and vomiting), headache, fatigue, sedation, dry mouth, vertigo, dizziness, restlessness, and photosensitivity. More studies are required to further investigate both short-term and long-term side effects of HP and to establish its safety profile when used as an antidepressant.[6]

    References

    1. ^McDonnell AM, Dang CHBasic review of the cytochrome p450 system.J Adv Pract Oncol.(2013-Jul)
    2. ^Bauer S, Störmer E, Johne A, Krüger H, Budde K, Neumayer HH, Roots I, Mai IAlterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patients.Br J Clin Pharmacol.(2003 Feb)
    3. ^Ng QX, Venkatanarayanan N, Ho CYClinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis.J Affect Disord.(2017-Mar-01)
    4. ^Hennessy M, Kelleher D, Spiers JP, Barry M, Kavanagh P, Back D, Mulcahy F, Feely JSt Johns wort increases expression of P-glycoprotein: implications for drug interactions.Br J Clin Pharmacol.(2002-Jan)
    5. ^Peterson B, Nguyen HSt John's WortStatPearls.(2023-05)
    6. ^Whiskey E, Werneke U, Taylor DA systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review.Int Clin Psychopharmacol.(2001-Sep)